Michael Torok

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Philadelphia, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jonathan Provoost, by power of attorney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Michael Torok

Form 4 holding Director

AMARIN CORP PLC\UK

Security class
Ordinary Shares
Shares / value
3,000,000
Estimated value
$1,950,000
Report date
03 Apr 2025
Price
$0.6500
Ownership
By JEC II Associates, LLC
Form 4 holding Director

AMARIN CORP PLC\UK

Security class
Ordinary Shares
Shares / value
970,000
Estimated value
$630,500
Report date
03 Apr 2025
Price
$0.6500
Ownership
Direct
Form 4 holding Director

AMARIN CORP PLC\UK

Security class
Ordinary Shares
Shares / value
880,000
Estimated value
$572,000
Report date
03 Apr 2025
Price
$0.6500
Ownership
By The MOS Trust
Form 4 holding Director

Carisma Therapeutics Inc.

Security class
Stock Option (Right to Buy)
Shares / value
19,350
Estimated value
Report date
26 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Michael Torok

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .